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Abstract
Purpose The objectives of this study were to analyze the
outcome after hepatectomy and to identify contributing factors
to mortality and long-term survival in a population-based
setting.
Method A retrospective, nationwide register study was per-
formed. All patients who underwent hepatectomy in Sweden
between 2002 and 2011 were identified in the Swedish
Hospital Discharge Registry using their unique personal iden-
tification numbers. This cohort was linked to the National
Cancer Registry (cancer diagnosis), the National Registry of
Causes of Death, and the Migration Registry. Survival analy-
sis by Kaplan-Meier method was performed to assess long-
term outcome. A Cox regression model was used to analyze
risk factors affecting long-term survival.
Results Overall, 4460 hepatectomies were performed. The
30- and 90-day mortalities were 1.8 and 3.1 %, respectively.
The overall 5- and 10-year survival rates for all diagnoses
were 45 and 38 %, respectively. Independent risk factors for
5-year mortality were as follows: patient age, comorbidity,
male gender, intrahepatic/extrahepatic cholangiocarcinoma,
gallbladder cancer, extent of hepatectomy, and hepatectomies
performed at non-university hospitals. Re-resection (78.1 %
with diagnosis Bmetastasis^) was performed on 374 patients.
In these patients, mortality risk decreased by >50 % (HR 0.42;
95 %, CI 0.33–0.53).
Conclusion In a population-based analysis, liver resections
are done with a low mortality risk and good long-term out-
come. Patients who underwent resection at a University
Hospital showed a significant better outcome compared to
patients resected at non-University Hospitals. These results
support further centralization of liver surgery. Re-resection
should be performed if feasible.
Keywords Hepatectomy . Outcome . Long-term survival .
Risk factors . Population based
Introduction
During the last 20 years, liver surgery has undergone substan-
tial changes mainly due to technical and medical innovations
and is considered to offer the best opportunity of cure in cases
of primary as well as secondary liver tumors [1–4].
Accordingly, the number of hepatectomies carried out has
been constantly growing concomitantly with a centralization
of these procedures into high volume academic centers [5, 6].
A variety of factors have been identified as contributing to
decreased postoperative mortality rates and improved long-
term survival rates [7–10]. However, the current literature is
biased by a predominance of single-institution studies emerg-
ing from highly specialized centers, and the results presented
do not necessarily reflect population-based short- and long-
term results [11–13]. Population-based studies on overall mor-
tality and long-term survival after hepatectomy are sparse.
Therefore, it is uncertain to which degree the implementation
and dissemination of changes in liver surgery has had any
impact on the general population. Mortality related to liver
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resections seems to be lower when performed at high-volume,
academic centers compared to low-volume, non-academic
centers [14, 15], and surgeon training has been found to be
highly predictive for post-operative complications [16]. This
was supported by a recently published population-based study
where Farges and colleagues concluded that reported mortality
figures in the literature probably underestimate the real mortality
risk associated with liver resection when population-based data
were carefully analyzed [15, 17].
In Sweden, population-based data are available for analy-
ses on both short-term results as well as long-term survival
after all surgical procedures by utilizing the national medical
registries [6, 18]. The objectives of the present study were to
analyze both the incidence and which factors may have influ-
enced the outcome of liver surgery in Sweden between 2002
and 2011.
Patients and methods
All patients who underwent hepatectomy in Sweden during a
10-year period (2002–2011) and have been registered in the
Swedish Hospital Discharge Registry were included in this
cohort study. This registry was founded in 1965, and since
1987, it includes all in-hospital patient contacts; these can be
traced through the patients’ national registration number for
identification. The register contains both medical data (e.g.,
diagnosis, comorbidity, and procedure code) and general
patient-related data (e.g., age, sex) but no specific information
of, e.g., patient medication. The National Cancer Registry was
set up in 1957 and collects cancer-related data like tumor site,
histological type of cancer, and date of diagnosis but no spe-
cific pathological data like resection margins or lymph node
status. In addition, the Registry of Causes of Death contains
the individuals’ death certificates with information such as
underlying disease and date of death. All registers are en-
dorsed and maintained by the Swedish Board of Health and
Welfare. For this specific study, we identified all patients by
their unique national registration numbers in the Hospital
Discharge Register while matching an in-hospital discharge
procedure code for liver resection according to the Tenth
Revision of the International Classification of Diseases and
Procedures (ICD 10 codes JJB00, JJB10, JJB20, JJB30,
JJB40, JJB50, JJB53, JJB60, JJB71, and JJB96). Then, the
personal national registration number was used for cross-
linkage with the Registry of Causes of Death to estimate post-
operative as well as long-term survival outcomes, and the
Registry of Domestic and International relocations was used
for censoring in the event of a cohort member emigrating. The
cohort was followed until December 31, 2011. A detailed
description of the methods used in this study has been de-
scribed elsewhere [19].
In the risk factor analysis, the variable age was categorized
into quartiles: ≤54, 55–63, 64–71, and ≥72 years, with the
study period divided into two 5-year intervals. The individual
patient’s comorbidity was classified according to the Charlson
score [20], modified due to the fact that almost all patients had
a diagnosis of malignancy, which was excluded from the
score. The respective variables were categorized into four
groups: no comorbidity, Charlson score 1–2, Charlson score
3–4, and Charlson score ≥ 5.
All liver resections, both open and laparoscopic, were
subdivided into three groups: minor (≤ 2 Couinaud segments),
major (3–4 Couinaud segments), and extended (>4 Couinaud
segments). Biopsies, ablations, and de-roofing of liver cysts
were excluded from the analysis. All identified patients were
stratified for diagnosis as stated in the discharge record as a
surrogate for the indication for surgery. Accordingly, we iden-
tified the following diagnoses: metastases (ICD10 code
C78.7), hepatocellular cancer (HCC, ICD10-code C22.0),
intrahepatic (ICC, ICD10-code C22.1) and extrahepatic bile
duct cancer (ECC, ICD10-code C24.0), gallbladder cancer
(GBC, ICD10-code C23.9), and others/unclear. The patients
with unclear diagnoses were then cross-linked with the
National Cancer Register and subsequently classified into
the corresponding identified group. A diagnosis of colorectal
cancer (ICD10-codes C18.0-C18.9, C19.9, C20.9) along with
a procedure code for liver resection was analyzed separately.
The remaining patients were categorized as either be-
nign or indefinite diagnosis. Hospitals were categorized
into non-university and university hospitals as well as
high-volume (>300 resections during the study period)
and low-volume centers.
For the risk factor analysis, hospitals were categorized as
high- and low-volume hospitals (cutoff 300 resections during
the study period), as well as university and non-university hos-
pitals (7 university, 33 non-university hospitals), respectively.
The Regional Research Ethics Committee of Stockholm ap-
proved the study protocol (DN 2010/1872-31/2).
Statistical analysis
Several patients had surgical liver procedures registered at
more than one time point, and each procedure was handled
as a separate event. Data were calculated as means ± standard
deviations for continuous variables, and proportions for cate-
gorical variables. Long-term survival rates after liver resection
were assessed by the Kaplan-Meier method.
Cox proportional hazard ratios (HRs) with 95 % confi-
dence intervals (CI) were used for univariable and multivari-
able assessments of the association between potential risk fac-
tors and the hazard; in other words, the risk of death of all
causes with time-at-risk as the underlying timescale was used.
Potential risk factors used in the regression modeling were
categorized in order to facilitate the analyses. Introducing
106 Langenbecks Arch Surg (2017) 402:105–113
the variables stepwise into the multivariable regression model
tested potential confounding effects, and the risk factors were
also tested for possible statistical interactions. P values <0.050
were considered to be statistically significant. Statistical anal-
yses were performed using SPSS Version 20 for Windows
(SPSS, Inc., Chicago, IL).
Results
During the study period, there was an increase in annual
number of liver resections. In total, 4460 (2381 (53.4 %)
female, 2079 (46.6 %) male) patients with a median age
of 64 were submitted to hepatic surgery. Of these, 374
patients underwent re-resection. Hepatectomies were con-
tinuously performed in 40 hospitals over the entire study
period. The proportion of liver resections performed in
academic compared to non-academic units is shown in
Fig. 1. The incidence of hepatic resections increased from
2.5 per 100,000 inhabitants in 2002 to 8.1 per 100,000
inhabitants in 2011. At the same time, the number of
minor resections increased from n = 1013 to n = 1832,
major resections from n = 479 to n = 791, and extended
resections from n = 127 to n = 218, when comparing the
first and second 5-year period. Major/extended hepatecto-
mies were almost exclusively performed at academic hos-
pitals (96 % during the first 5-year period and 99 % dur-
ing the second 5-year period). Kaplan-Meier estimation
revealed a significant better survival after minor resec-
tions as compared to major and extended resections
(Fig. 2). Median post-operative hospital stay over the en-
tire study period was 9 days after minor resection, 11 days
after major resection, and 13 days after extended resec-
tion, with no difference between the two study periods.
The 30- and 90-day mortality figures, stratified for the
extent of liver resection, are shown in detail in Table 1.
The overall 30- and 90-day mortality rates were 1.8 and
3.1 %, respectively. There was no significant difference of
postoperative mortality comparing the first with the sec-
ond study period. In contrast, a significant difference was
observed after hepatectomy performed in a non-university
compared to university hospitals. In non-university hospi-
tals, the 30- and 90-day mortality was 3.8 and 6.6 % and
in university hospitals 1.6 and 2.8 %, respectively. The
Kaplan-Meier estimation of survival after liver resection
in non-university and university hospitals is shown in
Fig. 3. In the majority of the cases (59 %), the indication
for hepatic resection was liver metastasis (n = 2644).
HCC was the diagnosis in 9 % (n = 393), GBC in 6 %
(n = 254), ICC in 3 % (n = 129), and ECC in 2 %
(n = 76). The remaining minor diagnosis groups were
2.5 % bowel cancer (without Bmetastasis^) (n = 110),
2 % other liver malignancies (n = 61), and 10 % other/
unclear diagnosis (n = 452). Finally, about 8 % of the
cases were found to have a benign diagnosis (n = 341).
The 5-year overall survival rate was 50 % for the diagno-
sis Bliver metastasis,^ 40 % for HCC, 38 % for GBC,
30 % for ICC, and 20 % for ECC. The related Kaplan-
Meier estimation is shown in Fig. 4.
Metastatic liver disease was the reason for 78 % of the re-
resections. For this group of patients, the survival rate was
significantly better after a second resection compared to those
patients with a single-resection only (Fig. 5).
Univariable and multivariable risk factor analysis for the
long-term outcome after liver resection is shown in detail in
Table 2. High age, comorbidity, as defined by a modified
Charlson score (described in the BMethods^ section), male
gender, and hepatectomy performed outside a university hos-
pital were identified as independent risk factors for death. Low
hospital volume was identified as a risk factor in the
univariable analysis, too, but was excluded in the multivari-
able analysis due to co-linearity with the status Buniversity/
non-university hospital.^ Accordingly, the diagnoses ICC,
ECC, and GBC were identified as additional independent risk
factors for death compared to patients with Bliver metastasis^
diagnosis. In addition, patients who underwent liver resection
at non-university hospitals had a significantly decreased long-
term survival rate compared with those who underwent sur-





















Fig. 1 Number of liver resections in university hospitals (n = 7) and non-
university hospitals (n = 33) in Sweden over the study period
Table 1 Postoperative 30- and 90-daymortality specified for the extent
of hepatectomy
Extent of resection n Mortality %
30 days 90 days
Minor resections 2845 (63.8 %) 1.4 2.3
Major resections 1271 (28.5 %) 2.1 3.2
Extended resections 344 (7.7 %) 4.3 7.5
Minor resections (≤2 Couinaud segments), major resection (3–4
Couinaud segments), extended resection (>4 Couinaud segments)
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Discussion
The present study demonstrates that hepatectomy is a safe
procedure and that related mortality was probably
overestimated in previous, non-population-based studies.
The extent of resection and primary liver cancers are indepen-
dent risk factors for post-operative mortality. Re-resection of
liver metastasis improved long-term survival significantly. On
Table 2 Univariable and
multivariable (Cox) regression
analysis of risk factors for
mortality (long-term survival)
n Univariable analysis Multivariable analysis
HR (95 % CI) P HR (95 % CI) P
Demography
Age ≤ 54 years 1067 1.00 1.00
Age 55–63 years 1143 1.39 (1.19–1.61) <0.001 1.16 (0.99–1.35) 0.061
Age 64–71 years 1226 1.90 (1.65–2.20) <0.001 1.55 (1.34–1.79) <0.001
Age ≥ 72 years 1024 2.43 (2.11–2.80) <0.001 1.90 (1.64–2.22) <0.001
Female sex 2079 1.00 1.00
Male sex 2381 1.20 (1.09–1.32) <0.001 1.11 (1.01–1.22) 0.037
Comorbidity
Charlson 0 3012 1.00 1.00
Charlson 1–2 1388 1.44 (1.30–1.59) <0.001 1.36 (1.22–1.50) <0.001
Charlson 3–4 39 1.90 (1.26–2.87) 0.002 1.83 (1.20–2.78) 0.005
Charlson ≥5 21 3.23 (1.90–5.47) <0.001 3.06 (1.80–5.21) <0.001
Diagnosis
CRCm 2644 1.00 1.00
HCC 393 1.23 (1.06–1.44) 0.008 1.16 (0.99–1.36) 0.060
ICC 129 1.78 (1.41–2.25) <0.001 1.76 (1.38–2.23) <0.001
ECC 254 2.21 (1.70–2.93) <0.001 2.15 (1.62–2.87) <0.001
GBC 76 1.42 (1.19–1.70) <0.001 1.53 (1.27–1.85) <0.001
CRC 110 0.97 (0.73–1.30) 0.848 0.71 (0.52–0.95) 0.023
Other malignancy 61 0.83 (0.55–1.26) 0.384 0.83 (0.55–1.26) 0.391
Benign 341 0.15 (0.10–0.22) <0.001 0.19 (0.13–0.28) <0.001
Other 452 0.68 (0.57–0.81) <0.001 0.74 (0.62–0.88) 0.001
Study period
2002–2006 1619 1.00
2007–2011 2841 1.05 (0.95–1.16) 0.393
Extent of hepatectomy
Minor 2845 1.00 1.00
Major 1270 1.24 (1.12–1.38) <0.001 1.18 (1.05–1.31) 0.004
Extended 345 1.64 (1.40–1.92) <0.001 1.10 (1.28–1.78) <0.001
Hospital volume
High volume 3730 1.00
Low volume 730 1.17 (1.05–1.32) 0.008
Hospital structure
University hospital 4096 1.00 1.00
Non-university uospital 338 1.46 (1.26–1.69) <0.001 1.57 (1.35–1.83) <0.001
Re-resection
No 4086 1.00 1.00
Yes 374 0.40 (0.31–0.50) <0.001 0.44 (0.34–0.56) <0.001
HR hazard ratio, 95%CI 95% confidence interval,CRCm colorectal cancer liver metastasis,HCC hepato-cellular
carcinoma, ICC intra-hepatic cholangiocarcinoma, ECC extra-hepatic cholangiocarcinomaGBC gallbladder can-
cer, CRC diagnosis of colorectal cancer coded for liver resection but without diagnosis Bmetastasis,^ other
malignancy, other liver malignancies, other, other and unclear diagnosis
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the other hand, patients who underwent liver resections at
non-university hospitals had a significantly worse outcome
compared to those being resected at university hospitals.
The total number of hepatectomies in Sweden grad-
ually increased during the study period (2002–2011).
As expected, we observed huge differences in long-
Fig. 2 Kaplan-Meier survival estimates for minor, major, and extended hepatectomy
Fig. 3 Kaplan-Meier survival estimates for hepatectomies performed at university vs non-university hospitals
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term outcomes depending on the underlying cancer
diagnosis when adjusted for complementary risk fac-
tors like age and comorbidity, for example.
Previous publications addressing the outcome after liver sur-
gery have mainly derived from single expert center experiences
with a good chance of underestimating the risks and
overestimating the results [15]. In Sweden, we have the oppor-
tunity to acquire medical information originating from the entire
population with an almost complete follow-up using various
national registries. An important methodological question
Fig. 4 Kaplan-Meier surival
estimates for different malign
diagnosis
Fig. 5 Kaplan-Meier survival
estimates for patients with single
and more than one liver resection
for metastatic disease
110 Langenbecks Arch Surg (2017) 402:105–113
emerges regarding the validity of these registers since the quality
of studies like this is totally dependent on data quality and cov-
erage. Previous validation studies have reported a 95% accuracy
concerning procedure codes in the Hospital Discharge Registry
and a close to a 100 % registration in the Registry of Causes for
Death and National Cancer Registry, respectively [21].
Therefore, it can be concluded that the registries used for this
study are reliable.
We were able to demonstrate a low postoperative mortality
after hepatic surgery and, as expected, a significant difference
in immediate post-operative outcomes depending on the ex-
tent of hepatic resection. The 90-day mortality rate was about
twice that of the 30-day mortality rate, which confirms previ-
ous observations regarding the limited value of reporting 30-
daymortality figures only [22]. However, the mortality figures
in Sweden differ from those reported by Farges et al. [17],
who studied the 30- and 90-day mortality risks after liver
resection in France between 2007 and 2009, and found them
to be 3.4 and 5.8 %, respectively. This could partly be ex-
plained by a lower incidence of liver resections in Sweden
compared to France, implying a more conservative selection
of patients. Furthermore, HCC was not analyzed separately in
the French study. It is reasonable to assume that hepatectomies
due to HCC are more common in France than in Sweden,
where only 9 % of all hepatectomies were performed for this
indication. Moreover, in both countries, there might be a dif-
ferent case mix, too, that could influence the overall survival
numbers. Despite an increase of major/extended liver resec-
tions of almost 100 % in the second study period, the postop-
erative mortality figures remained unchanged. The most likely
explanation behind this favorable development is that the in-
crease in the number of complex hepatectomies was exclu-
sively seen at high volume university hospitals and as many as
99 % of major/extended hepatectomies were centralized to
these units during the second study period. This development
implies improved training of liver surgeons, something that
has previously been reported as a major predictive factor for
patient outcome after hepatectomy [5]. This conclusion is also
supported by our finding that 30- and 90-day mortality is
significantly higher for hepatectomies performed in low-vol-
ume, non-academic centers compared to university hospitals.
Regarding the long-term prognosis after surgery for prima-
ry and secondary liver cancers, we were able to define some
independent risk factors for death. High age, severe comor-
bidity, and male gender were identified as patient-specific risk
factors. Concerning the underlying cancer diagnosis, the
highest risk of mortality was related to cholangiocarcinoma,
gallbladder cancer, and hepatocellular cancer. In contrast, pa-
tients undergoing hepatectomy due to liver metastasis showed
a significantly better 5-year survival, confirming earlier
reports [8, 14, 23]. The significantly higher short-term mortal-
ity and worse long-term outcome after liver surgery in non-
academic compared to academic units cannot be explained by,
e.g., a higher frequency of synchronous procedures directed
toward both the primary tumor and liver metastases but
remained as an independent risk factor even in the multivari-
able analysis. Hence, it is tempting to speculate that surgeon/
staff training and less radical surgery are reasons behind these
results. Undoubtedly, these data further support the ongoing
trend of centralization of corresponding surgical procedures to
high volume centers.
In addition, we observed a significant survival benefit for
patients after re-resection for liver metastasis. With this, we
were able to confirm earlier reports deriving from single insti-
tutions in a population-based setting [24–27]. Given the pos-
sible impact of the selection of patients undergoing re-resec-
tion, our data provides evidence to justify an aggressive sur-
gical approach in the individual patient and support the con-
clusion made by Antoniou and co-workers that re-resection
should be encouraged whenever possible and feasible [9].
Conclusion
In Sweden, liver surgery has expanded significantly during the
last decade and is now practiced with a favorable postopera-
tive risk profile. However, those with primary liver cancers
still suffer a poor chance of long-term survival. Superior out-
come of patients from University Hospitals support further
centralization of liver surgery to high volume centers. In pa-
tients with liver metastases, re-resection should be performed
if possible.
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Appendix
No. at risk.
Years 0 2 4 6 8 10
Minor 2845 1610 837 359 134 2
Major 1270 702 350 157 48 0
Extended 345 179 88 42 14 0
No. at risk.
Years 0 2 4 6 8 10
University 4096 2295 1160 490 164 2
Non-university 364 196 115 68 32 0
No. at risk.
Years 0 2 4 6 8 10
CRM 2644 1453 676 248 74 2
HCC 393 213 105 51 13 0
GBC 254 120 63 31 10 0
ICC 129 57 22 11 5 0
ECC 76 31 13 3 1 0
No. at risk.
Years 0 2 4 6 8 10
Single resection 2380 1261 562 209 64 1
Re-do resection 268 192 114 39 10 1
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